NBB ... if we get some significant upward pps movement, and depending on the BT path, studies, and time-frame to NDA, maybe it is time to start flashing Rothschild again? Getting to Naz would be a big deal. It would also be a threat to interested and potential BP purchasers, if you have a "plan" for potentially doing it alone or with Hepalink/Ori possibly, without them. 

Still want to hear more details about the BT path, next steps, time-frames, etc. Plus, whatever regulatory status news is coming from Europe and Asia? I would have to think Europe and Asia will be at least as positive as the FDA, and add more pressure and momentum? Plus, still waiting for CKD data? ... a big domino today, with more to come?

Creating a big game of chicken for interested competitive BP's? :)